Veeva EDC Alternatives

Compare Veeva EDC alternatives: EDC and clinical trial software with eConsent, ePRO, and 21 CFR Part 11–aligned controls for early-phase trials.

21 CFR Part 11–aligned · HIPAA-aligned security · No credit card required

Overview

Veeva EDC Alternatives

Veeva Vault EDC is used by many pharma and biotech teams for clinical data capture. Teams evaluating Veeva EDC often look for alternatives that offer faster implementation, integrated eConsent and ePRO in one platform, and pricing that fits early-phase and small-to-mid-size studies. This page is for sponsors and CROs actively comparing EDC vendors or looking for a lighter, faster option. Capture is one alternative: a single platform for EDC, eConsent, ePRO, and safety with 21 CFR Part 11–aligned controls and HIPAA-aligned security, built for speed and flexibility without enterprise overhead.

Why teams look for Veeva EDC alternatives

Veeva Vault EDC is built for enterprise and large trials. Many early-phase and small biotech teams find that implementation timelines, pricing, and scope are geared toward larger programs. If you need rapid go-live, integrated eConsent and ePRO, and 21 CFR Part 11–aligned controls without long implementation or enterprise complexity, evaluating alternatives is common. Transparent comparison criteria include implementation speed, pricing fit, eConsent/ePRO integration, and support for sponsor validation.

What to look for when comparing EDC alternatives

  • Implementation speed and time to first patient
  • Pricing model: per-seat vs. study-based; fit for early-phase and small trials
  • Integrated eConsent, ePRO, and EDC in one platform and one audit trail
  • 21 CFR Part 11–aligned controls and HIPAA-aligned security
  • Documentation and support for sponsor validation and UAT
  • Export for analysis and regulatory submissions

Why teams consider alternatives to Veeva EDC

  • Long implementation cycles and change control for early-phase studies
  • Pricing and contracts geared toward enterprise and large trials
  • Separate or complex setup for eConsent and ePRO
  • Need for a lighter, faster option for Phase 1–2 and small biotech

Where Capture fits as an alternative

  • Single platform for EDC, eConsent, ePRO, and safety; one audit trail
  • Rapid study build and deployment; no enterprise implementation overhead
  • 21 CFR Part 11–aligned controls and HIPAA-aligned security
  • Documentation to support sponsor validation (Enterprise); pricing that scales with study size
  • Built for early-phase and mid-size trials; compare options or book a demo to evaluate fit

Related

Medidata alternativesEDC for Phase 1 trialsFeatures

FAQ

Questions we hear a lot

Who is this Veeva EDC alternatives page for?
Sponsors and CROs actively comparing EDC vendors or looking for a lighter, faster option for early-phase and mid-size trials. If you need rapid go-live and integrated eConsent/ePRO without enterprise complexity, evaluating alternatives is common.
What should I compare when evaluating EDC alternatives?
Consider implementation speed, pricing fit for your study size, whether eConsent and ePRO are integrated, 21 CFR Part 11–aligned controls, and support for sponsor validation. Capture offers one platform with these attributes for early-phase and mid-size trials.
Is Capture 21 CFR Part 11–aligned?
Yes. Capture is designed with 21 CFR Part 11–aligned controls (electronic signatures, audit trails, access control) and HIPAA-aligned security. We provide documentation to support sponsor validation when required (Enterprise).

Ready to see Capture in action?

Explore the platform with a free sandbox. No sales call required.